DK3740475T3 - Fremgangsmåde til fremstilling af somatostatinmodulatorer - Google Patents
Fremgangsmåde til fremstilling af somatostatinmodulatorer Download PDFInfo
- Publication number
- DK3740475T3 DK3740475T3 DK19740733.1T DK19740733T DK3740475T3 DK 3740475 T3 DK3740475 T3 DK 3740475T3 DK 19740733 T DK19740733 T DK 19740733T DK 3740475 T3 DK3740475 T3 DK 3740475T3
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- manufacture
- somatostatin modulators
- somatostatin
- modulators
- Prior art date
Links
- 102000005157 Somatostatin Human genes 0.000 title 1
- 108010056088 Somatostatin Proteins 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
- 229960000553 somatostatin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Optical Communication System (AREA)
- Eye Examination Apparatus (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862618538P | 2018-01-17 | 2018-01-17 | |
| PCT/US2019/013844 WO2019143718A1 (en) | 2018-01-17 | 2019-01-16 | Process of making somatostatin modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3740475T3 true DK3740475T3 (da) | 2022-07-11 |
Family
ID=67213594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19740733.1T DK3740475T3 (da) | 2018-01-17 | 2019-01-16 | Fremgangsmåde til fremstilling af somatostatinmodulatorer |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US10464918B2 (da) |
| EP (2) | EP3740475B1 (da) |
| JP (2) | JP7113900B2 (da) |
| KR (1) | KR102462586B1 (da) |
| CN (1) | CN111868049B (da) |
| AU (1) | AU2019209469B2 (da) |
| BR (1) | BR112020014462A2 (da) |
| CA (1) | CA3088658A1 (da) |
| DK (1) | DK3740475T3 (da) |
| EA (1) | EA202091559A1 (da) |
| ES (1) | ES2923529T3 (da) |
| HR (1) | HRP20220852T1 (da) |
| HU (1) | HUE059184T2 (da) |
| IL (1) | IL276029B1 (da) |
| LT (1) | LT3740475T (da) |
| MA (1) | MA51625B1 (da) |
| MD (1) | MD3740475T2 (da) |
| MX (1) | MX2020007586A (da) |
| PL (1) | PL3740475T3 (da) |
| PT (1) | PT3740475T (da) |
| RS (1) | RS63387B1 (da) |
| SG (1) | SG11202006838VA (da) |
| SI (1) | SI3740475T1 (da) |
| TW (1) | TWI823891B (da) |
| UA (1) | UA127355C2 (da) |
| WO (1) | WO2019143718A1 (da) |
| ZA (1) | ZA202004497B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201900349VA (en) | 2016-07-14 | 2019-02-27 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| WO2019143718A1 (en) | 2018-01-17 | 2019-07-25 | Crinetics Pharmaceuticals, Inc. | Process of making somatostatin modulators |
| MX2023002761A (es) | 2020-09-09 | 2023-04-03 | Crinetics Pharmaceuticals Inc | Formulaciones de un modulador de somatostatina. |
| CN113214050B (zh) * | 2021-05-15 | 2022-07-19 | 宁夏忠同生物科技有限公司 | 一种合成2,3,5,6-四氟苯酚的方法 |
| TW202339747A (zh) * | 2022-01-11 | 2023-10-16 | 美商克林提克斯醫藥股份有限公司 | 生長抑制素調節劑用於治療類癌症候群(carcinoid syndrome)之用途 |
| WO2023238112A1 (en) | 2022-06-10 | 2023-12-14 | Assia Chemical Industries Ltd. | Solid state forms of paltusotine and process for preparation thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1035154A (en) | 1910-05-16 | 1912-08-13 | Ernest G Clark | Machine for rectifying perforated music and masters. |
| US1046491A (en) | 1910-08-24 | 1912-12-10 | Alfred Randolph | Gas-engine. |
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| CA2468159A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 4-aminoquinoline compounds |
| RU2298002C2 (ru) * | 2002-02-04 | 2007-04-27 | Ф. Хоффманн-Ля Рош Аг | Производные хинолина в качестве антагонистов npy |
| US7767817B2 (en) | 2003-09-05 | 2010-08-03 | Binghe Wang | Water soluble boronic acid fluorescent reporter compounds and methods of use thereof |
| US7648984B2 (en) | 2004-07-13 | 2010-01-19 | Glaxo Group Limited | Antibacterial agents |
| AU2007309708A1 (en) | 2006-03-13 | 2008-05-02 | Merck Sharp & Dohme Corp. | Somatostatin agonists |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| AU2011282588B2 (en) | 2010-07-30 | 2016-01-07 | Oncotherapy Science, Inc. | Quinoline derivatives and MELK inhibitors containing the same |
| EP2726465A1 (en) * | 2011-05-23 | 2014-05-07 | Elan Pharmaceuticals Inc. | Inhibitors of lrrk2 kinase activity |
| WO2013050996A2 (en) | 2011-10-05 | 2013-04-11 | Mapi Pharma Ltd. | Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids |
| EP2871179A4 (en) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
| JP6251277B2 (ja) | 2012-10-16 | 2017-12-20 | ヤンセン ファーマシューティカ エヌ．ベー． | ＲＯＲ−ガンマ−ｔのフェニル結合キノリニルモジュレーター |
| SG11201602477YA (en) * | 2013-09-30 | 2016-05-30 | Ono Pharmaceutical Co | Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| WO2016049568A1 (en) | 2014-09-25 | 2016-03-31 | Araxes Pharma Llc | Methods and compositions for inhibition of ras |
| WO2017003724A1 (en) * | 2015-07-01 | 2017-01-05 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US9957267B2 (en) | 2015-07-01 | 2018-05-01 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| SG11201900349VA (en) | 2016-07-14 | 2019-02-27 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| WO2019143718A1 (en) | 2018-01-17 | 2019-07-25 | Crinetics Pharmaceuticals, Inc. | Process of making somatostatin modulators |
-
2019
- 2019-01-16 WO PCT/US2019/013844 patent/WO2019143718A1/en unknown
- 2019-01-16 AU AU2019209469A patent/AU2019209469B2/en active Active
- 2019-01-16 ES ES19740733T patent/ES2923529T3/es active Active
- 2019-01-16 UA UAA202004625A patent/UA127355C2/uk unknown
- 2019-01-16 MX MX2020007586A patent/MX2020007586A/es unknown
- 2019-01-16 PT PT197407331T patent/PT3740475T/pt unknown
- 2019-01-16 IL IL276029A patent/IL276029B1/en unknown
- 2019-01-16 JP JP2020538675A patent/JP7113900B2/ja active Active
- 2019-01-16 RS RS20220660A patent/RS63387B1/sr unknown
- 2019-01-16 MD MDE20201200T patent/MD3740475T2/ro unknown
- 2019-01-16 CA CA3088658A patent/CA3088658A1/en active Pending
- 2019-01-16 EP EP19740733.1A patent/EP3740475B1/en active Active
- 2019-01-16 EA EA202091559A patent/EA202091559A1/ru unknown
- 2019-01-16 US US16/249,729 patent/US10464918B2/en active Active
- 2019-01-16 BR BR112020014462-2A patent/BR112020014462A2/pt active Search and Examination
- 2019-01-16 EP EP22168295.8A patent/EP4092018A1/en not_active Withdrawn
- 2019-01-16 HU HUE19740733A patent/HUE059184T2/hu unknown
- 2019-01-16 HR HRP20220852TT patent/HRP20220852T1/hr unknown
- 2019-01-16 SG SG11202006838VA patent/SG11202006838VA/en unknown
- 2019-01-16 DK DK19740733.1T patent/DK3740475T3/da active
- 2019-01-16 LT LTEPPCT/US2019/013844T patent/LT3740475T/lt unknown
- 2019-01-16 KR KR1020207023546A patent/KR102462586B1/ko active IP Right Grant
- 2019-01-16 PL PL19740733.1T patent/PL3740475T3/pl unknown
- 2019-01-16 CN CN201980019970.7A patent/CN111868049B/zh active Active
- 2019-01-16 SI SI201930277T patent/SI3740475T1/sl unknown
- 2019-01-16 MA MA51625A patent/MA51625B1/fr unknown
- 2019-01-17 TW TW108101800A patent/TWI823891B/zh active
- 2019-10-03 US US16/592,595 patent/US10889561B2/en active Active
-
2020
- 2020-07-21 ZA ZA2020/04497A patent/ZA202004497B/en unknown
- 2020-12-09 US US17/116,728 patent/US20210087165A1/en not_active Abandoned
-
2022
- 2022-07-26 JP JP2022118926A patent/JP2022166016A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3740475T3 (da) | Fremgangsmåde til fremstilling af somatostatinmodulatorer | |
| DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
| DK3642374T3 (da) | Fremgangsmåde til ekstraktion af lithiumforbindelse(r) | |
| DK3668851T3 (da) | Fremgangsmåde til fremstilling af thiocarbonater | |
| DK3368683T3 (da) | Fremgangsmåde til kvantifikationen af pd-l1 | |
| DK3563156T3 (da) | Fremgangsmåde til separering af biomolekyler | |
| DK3891145T3 (da) | Modulatorer af trex1 | |
| DK3472221T3 (da) | Blanding til hærdning af epoxyresinsammensætninger | |
| DK3390456T3 (da) | Fremgangsmåde til fremstilling af parenchymcellecellulose | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3612845T3 (da) | Fremgangsmåde til kontaktløs bestemmelse af flowparametre | |
| DK3596106T3 (da) | Fremgangsmåde til konstruktion af peptidbibliotek | |
| DK3573620T3 (da) | Sammensætninger til behandling af hypertension | |
| DK3889374T3 (da) | Fremgangsmåde til konstruktion af bygninger | |
| DK3548427T3 (da) | Fremgangsmåde til fremstilling af hydrogen | |
| DK3891642T3 (da) | Fremgangsmåde til sikring af pålideligheden af kildekoder | |
| DK3678648T3 (da) | Fremgangsmåder til anvendelse af dipivefrin | |
| DK3567245T3 (da) | Drift af vindmølle | |
| DK3507282T3 (da) | Fremgangsmåde til fremstilling af indolcarboxamidforbindelser | |
| DK3548626T3 (da) | Fremgangsmåde til fremstilling af biogas af fiberholdigt substrat | |
| DK3713513T3 (da) | Fremgangsmåde til fremstilling af en protesedel | |
| DK3700941T3 (da) | Fremgangsmåde til fremstilling af modificeret hemicellulose | |
| DK3519381T3 (da) | Fremgangsmåde til fremstilling af calciumdiglyceroxid | |
| DK3880802T3 (da) | Forbedret fremgangsmåde til fremstilling af t-celler | |
| DK3544068T3 (da) | Fremgangsmåde til fremstilling af termoelektriske mikrokølere |